WO2000051578A3 - Use of ceramides for the treatment of cystic fibrosis - Google Patents
Use of ceramides for the treatment of cystic fibrosis Download PDFInfo
- Publication number
- WO2000051578A3 WO2000051578A3 PCT/EP2000/001682 EP0001682W WO0051578A3 WO 2000051578 A3 WO2000051578 A3 WO 2000051578A3 EP 0001682 W EP0001682 W EP 0001682W WO 0051578 A3 WO0051578 A3 WO 0051578A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ceramides
- treatment
- cystic fibrosis
- substances
- relates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00909267A EP1156854A2 (en) | 1999-03-03 | 2000-02-29 | Use of ceramides for the treatment of cystic fibrosis |
CA002365290A CA2365290A1 (en) | 1999-03-03 | 2000-02-29 | Use of ceramides for the treatment of cystic fibrosis |
AU31613/00A AU3161300A (en) | 1999-03-03 | 2000-02-29 | Use of ceramides for the treatment of cystic fibrosis |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19909115A DE19909115A1 (en) | 1999-03-03 | 1999-03-03 | Use of ceramides to treat cystic fibrosis |
DE19909115.3 | 1999-03-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000051578A2 WO2000051578A2 (en) | 2000-09-08 |
WO2000051578A3 true WO2000051578A3 (en) | 2001-01-04 |
Family
ID=7899443
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2000/001682 WO2000051578A2 (en) | 1999-03-03 | 2000-02-29 | Use of ceramides for the treatment of cystic fibrosis |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1156854A2 (en) |
AU (1) | AU3161300A (en) |
CA (1) | CA2365290A1 (en) |
DE (1) | DE19909115A1 (en) |
WO (1) | WO2000051578A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2558429C (en) | 2004-03-02 | 2011-02-01 | Mcgill University | Compositions and methods for preventing or treating an inflammatory response |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0074251A1 (en) * | 1981-09-04 | 1983-03-16 | Yeda Research And Development Company, Ltd. | Novel lipid fraction, its preparation and pharmaceutical compositions containing same |
WO1985003638A1 (en) * | 1984-02-23 | 1985-08-29 | Yeda Research And Development Ltd. | Compositions containing active lipids |
US4766111A (en) * | 1985-10-31 | 1988-08-23 | Trustees Of Boston University | Lipids with plasmin inhibitory properties |
EP0450991A2 (en) * | 1990-02-20 | 1991-10-09 | Synthelabo | Use of phosphatidylglycerol(diC 18:10)in the treatment of obstructive airway diseases |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3819870A1 (en) * | 1987-06-12 | 1988-12-29 | Hoerrmann Wilhelm | Pharmaceuticals based on fatty amino alcohols |
US5753613A (en) * | 1994-09-30 | 1998-05-19 | Inex Pharmaceuticals Corporation | Compositions for the introduction of polyanionic materials into cells |
ATE219660T1 (en) * | 1994-09-30 | 2002-07-15 | Inex Pharmaceuticals Corp | AGENT FOR INTRODUCING POLYANIONIC MATERIALS INTO CELLS |
-
1999
- 1999-03-03 DE DE19909115A patent/DE19909115A1/en not_active Withdrawn
-
2000
- 2000-02-29 AU AU31613/00A patent/AU3161300A/en not_active Abandoned
- 2000-02-29 CA CA002365290A patent/CA2365290A1/en not_active Abandoned
- 2000-02-29 WO PCT/EP2000/001682 patent/WO2000051578A2/en not_active Application Discontinuation
- 2000-02-29 EP EP00909267A patent/EP1156854A2/en not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0074251A1 (en) * | 1981-09-04 | 1983-03-16 | Yeda Research And Development Company, Ltd. | Novel lipid fraction, its preparation and pharmaceutical compositions containing same |
WO1985003638A1 (en) * | 1984-02-23 | 1985-08-29 | Yeda Research And Development Ltd. | Compositions containing active lipids |
US4766111A (en) * | 1985-10-31 | 1988-08-23 | Trustees Of Boston University | Lipids with plasmin inhibitory properties |
EP0450991A2 (en) * | 1990-02-20 | 1991-10-09 | Synthelabo | Use of phosphatidylglycerol(diC 18:10)in the treatment of obstructive airway diseases |
Non-Patent Citations (5)
Title |
---|
BURDGE G C ET AL: "PLASMA LIPID CONCENTRATIONS IN CHILDREN WITH CYSTIC FIBROSIS: THE VALUE OF A HIGH-FAT DIET AND PANCREATIC SUPPLEMENTATION", BRITISH JOURNAL OF NUTRITION,CAMBRIDGE,GB, vol. 71, no. 6, June 1994 (1994-06-01), pages 959 - 964, XP000951637 * |
GIROD S ET AL: "PHOSPHOLIPID COMPOSITION AND SURFACE-ACTIVE PROPERTIES OF TRACHEOBRONCIAL SECRETIONS FROM PATIENTS WITH CYSTIC FIBROSIS AND CHRONIC OBSTRUCTIVE PULMONARY DISEASES", PEDIATRIC PULMONOLOGY,JOHN WILEY, NEW YORK, NY,US, vol. 13, no. 1, May 1992 (1992-05-01), pages 22 - 27, XP000952015, ISSN: 8755-6863 * |
GRIESE M ET AL: "PULMONARY SURFACTANT IN CYSTIC FIBROSIS", EUROPEAN RESPIRATORY JOURNAL,DK,MUNKSGAARD INTERNATIONAL PUBLISHERS, COPENHAGEN, vol. 10, no. 9, September 1997 (1997-09-01), pages 1983 - 1988, XP000891384, ISSN: 0903-1936 * |
KUIJCK VAN M A ET AL: "MOLECULAR CLONING AND EXPRESSION OF A CYCLIC AMP-ACTIVATED CHLORIDECONDUCTANCE REGULATOR: A NOVEL ATP-BINDING CASSETTE TRANSPORTER", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA,NATIONAL ACADEMY OF SCIENCE. WASHINGTON,US, vol. 93, no. 11, May 1996 (1996-05-01), pages 5401 - 5406, XP000946726, ISSN: 0027-8424 * |
SZABO I ET AL: "TYROSINE KINASE-DEPENDENT ACTIVATION OF A CHLORIDE CHANNEL IN CD95-INDUCED APOPTOSIS IN T LYMPHOCYTES", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA,NATIONAL ACADEMY OF SCIENCE. WASHINGTON,US, vol. 95, no. 11, 26 May 1998 (1998-05-26), pages 6169 - 6174, XP000946287, ISSN: 0027-8424 * |
Also Published As
Publication number | Publication date |
---|---|
EP1156854A2 (en) | 2001-11-28 |
DE19909115A1 (en) | 2000-09-07 |
AU3161300A (en) | 2000-09-21 |
CA2365290A1 (en) | 2000-09-08 |
WO2000051578A2 (en) | 2000-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001002992A8 (en) | System and method for extension of group buying throughout the internet | |
AU2001262723A1 (en) | 1,2-dihydropyridine compounds, process for preparation of the same and use thereof | |
AU7165698A (en) | Use of quinazoline compounds for the treatment of polycystic kidney disease | |
AU6405198A (en) | Plant for the treatment of products, which includes means for characterizing the products | |
FI960278A0 (en) | Method for the preparation of anatase titanium dioxide | |
AU2002213887A1 (en) | Process for the antimicrobial treatment of fiber materials | |
AU1774097A (en) | Pharmaceutical compositions for the treatment of rhinitis | |
AU6083899A (en) | Combination of c1-inh and lung surfactant for the treatment of respiratory disorders | |
AU2001269704A1 (en) | Oxazinoquinolones useful for the treatment of viral infections | |
DE69527143T2 (en) | ROLLING MILL FOR THE PRODUCTION OF ANGLE STEEL FROM STRAP STEEL | |
AU4998100A (en) | Methods of using percarboxylic acid or anions thereof and methods of making the same | |
AU4774697A (en) | Use of 1-hydroxy-2-pyridone for the treatment of seborrheic dermatitis | |
AU2021601A (en) | Composition for the treatment of dandruff | |
HK1044897A1 (en) | Method of treating angina and/or anginal equivalents, and pharmaceutical compositions and kit related thereto | |
WO2000051578A3 (en) | Use of ceramides for the treatment of cystic fibrosis | |
AU4228000A (en) | Methods and compositions for the treatment and prevention of lung disease | |
AU3059795A (en) | Cosmetic composition which prevents or attenuates the photo-reactivity of titanium dioxide nanopigments | |
NO981499L (en) | Process for the preparation of titanium dioxide | |
DE69812861D1 (en) | ROLLING MILL FOR THE PRODUCTION OF AXIAL-SYMMETRICAL PARTS | |
AU2001286489A1 (en) | Process for the purification of iosoctane and/or diisobutylene | |
AU2002256095A1 (en) | Method for the treatment of polycystic kidney disease | |
AU2002251202A1 (en) | Intimins for the prevention or treatment of infections: i | |
FI946041A (en) | Process for the preparation of titanium dioxide | |
AU1341895A (en) | A biocide composition for the treatment of timber | |
AU1673200A (en) | Medicaments for the treatment of lung infections |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
ENP | Entry into the national phase |
Ref document number: 2365290 Country of ref document: CA Ref country code: CA Ref document number: 2365290 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000909267 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2000909267 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09914594 Country of ref document: US |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000909267 Country of ref document: EP |